Studies

Showing 120 studies.

IMPAACT 2002: Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression among Youth Living with HIV in the United States

DAIDS Number

Research Area

Complications & Comorbidities

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2001: A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women with Latent Tuberculosis Infection

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2000: A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID delta M2-2 in RSV-Seronegative Infants and Children

DAIDS Number

Research Area

Complications & Comorbidities

Study Status

P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

Research Area

Study Status

P1114: Safety and Immunogenicity of an RSV Vaccine cps2

DAIDS Number

Research Area

Complications & Comorbidities

Study Status

P1113: AERAS-404 TB Vaccine in BCG-Primed Infants

DAIDS Number

Research Area

Study Status

Closed to Follow Up

P1112: Monoclonal Antibody PK Study

DAIDS Number

Research Area

Study Status

Closed to Accrual

P1111: Safety, Tolerability and PK of Rilpivirine

DAIDS Number

Research Area

Antiretroviral Strategies

Study Status

P1110: Safety and PK of RAL in Neonates

DAIDS Number

Research Area

P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) in Combination with Optimized Individualized Multidrug-Resistant Tuberculosis (MDR-TB) Therapy in HIV-Infected and HIV-Uninfected Infants, Children and Adolescents with MDR-TB Disease

DAIDS Number

Research Area

Study Status